<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="0" ids="6067">Isotretinoin</z:chebi> is remarkably effective in the treatment of severe cystic <z:hpo ids='HP_0001061'>acne</z:hpo>, however, many complications have been observed during treatment and new toxic effects have been reported </plain></SENT>
<SENT sid="1" pm="."><plain><z:hpo ids='HP_0002155'>Hypertriglyceridemia</z:hpo> associated with decreases in <z:chebi fb="6" ids="39025">high density lipoprotein</z:chebi> (<z:chebi fb="17" ids="39025">HDL</z:chebi>) cholesterol has occurred in 25 percent of patients and requires monitoring during treatment </plain></SENT>
<SENT sid="2" pm="."><plain>Painful <z:mpath ids='MPATH_580'>erosions</z:mpath> with <z:mpath ids='MPATH_183'>granulation tissue</z:mpath> recently have been reported in patients with severe <z:hpo ids='HP_0001061'>acne</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>Other complications have included <z:hpo ids='HP_0007759'>corneal opacities</z:hpo>, <z:e sem="disease" ids="C0033845" disease_type="Disease or Syndrome" abbrv="">pseudotumor cerebri</z:e>, <z:hpo ids='HP_0003072'>hypercalcemia</z:hpo>, <z:hpo ids='HP_0000992'>photosensitivity</z:hpo> reactions, <z:hpo ids='HP_0002910'>abnormal liver function tests</z:hpo>, and skeletal <z:hpo ids='HP_0100774'>hyperostosis</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain><z:chebi fb="0" ids="6067">Isotretinoin</z:chebi> is teratogenic and should be avoided during pregnancy </plain></SENT>
<SENT sid="5" pm="."><plain>With the increasing acceptance and use of <z:chebi fb="0" ids="6067">isotretinoin</z:chebi> for cystic <z:hpo ids='HP_0001061'>acne</z:hpo>, as well as related disorders (inflammatory papulopustular <z:hpo ids='HP_0001061'>acne</z:hpo> with <z:hpo ids='HP_0100699'>scarring</z:hpo>, <z:mp ids='MP_0001795'>gram-negative</z:mp> <z:mp ids='MP_0000376'>folliculitis</z:mp>, and <z:hpo ids='HP_0001061'>acne</z:hpo> <z:e sem="disease" ids="C0035854" disease_type="Disease or Syndrome" abbrv="">rosacea</z:e>), a reevaluation of <z:chebi fb="0" ids="6067">isotretinoin</z:chebi> aimed at reducing complications is in order </plain></SENT>
<SENT sid="6" pm="."><plain>Patient selection criteria and guidelines directed at reducing these complications are presented </plain></SENT>
</text></document>